Air Pollution Linked to Heart Disease
Scientists hoped to examine how brief air pollution reductions would affect the heart. Using an interesting location -- the 2008 Beijing Olympics -- they found that even short-term drops in pollution exposure improve cardiovascular health.
Is Your Lung Connected to Heart Failure
Poor lung function may be more than just a symptom of respiratory disease. A new study has shown a link between lung function and the increased risk of heart failure.
Heart Health and COPD
Patients with chronic obstructive pulmonary disease (COPD) don't just need to worry about their lungs. In order to maximize the quality of life, they also need to monitor their heart health.
COPD Patients At Greater Heart Disease Risk
Not all chronic obstructive pulmonary disease (COPD) patients are at the same risk. A recent study has found that COPD patients with reduced lung function are more likely to develop heart disease.
Overly Thin COPD Patients at Added Risk
Being underweight isn't healthy in general, but it can be especially dangerous for Chronic Obstructive Pulmonary Disease patients.
America is Up In Smokes
Tobacco use is the most preventable cause of death in the United States, yet so many Americans choose to continue day after day. The rates are slowly declining, but by how much?
Label Warnings Updated for Chantix
U.S. Food and Drug Administration (FDA) officials have approved an updated drug label for smoking cessation medication varenicline (Chantix) with stronger warnings.
A Plume of Hope for Oil Spill Victims
Picking up the pieces for Gulf Coast residents has been no small feat. In early 2010, the Deepwater Horizon oil spill leaked nearly 5 million barrels of oil into the Gulf of Mexico, possibly causing a public health crisis.
Up in Smoke
There's no question that the wildfire sweeping across drought-stricken areas of the United States can be devastating. New research suggests that more than your property is at risk.
FDA: Chantix (varenicline) May Increase Cardiovascular Risk
The U.S. Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix ( varenicline ) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.